"Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems for use in respiratory care, acute care surgery and the treatment of obstructive sleep apnea. Our products are sold in over 120 countries worldwide."

During the past decade, Fisher & Paykel Healthcare conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 4 clinical trials were completed, i.e. on average, 23.5% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Fisher & Paykel Healthcare" are "Obstructive Sleep Apnea" (14 trials), "Sleep Disordered Breathing" (7 trials), "Congestive Heart Failure" (1 trials), "Obesity Hypoventilation Syndrome" (1 trials) and "Obstructive Sleep Apnea (OSA)" (1 trials). Many other conditions were trialed in "Fisher & Paykel Healthcare" in a lesser frequency.

Most popular intervention types in "Fisher & Paykel Healthcare" are "Device" (17 trials). Other intervention types were less common.

The name of intervention was led by "Alternative sizing model based trial mask" (1 trials), "Auto CPAP + comfort feature A" (1 trials), "Auto CPAP with comfort feature A+B" (1 trials), "Auto CPAP with comfort feature B" (1 trials) and "Auto CPAP with no comfort feature" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fisher & Paykel Healthcare" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Fisher & Paykel Healthcare". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Fisher & Paykel Healthcare, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Fisher & Paykel Healthcare, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 17 trials that are defined as “Not Applicable".